June 27th 2022
By Ryan McDonald
Treatment with the novel CAR-T cell therapy was associated with favorable efficacy and safety results in a group of patients with follicular lymphoma, including a few with Waldenstrom macroglobulinemia, according to findings from a study presented at a recent medical conference.
June 27th 2022
By Colleen Moretti
Receiving a diagnosis of metastatic breast cancer that has spread to the brain can be a frightening time for patients, however a new resource may help guide them through the stressful journey.
June 27th 2022
By Steve Rubin
After cancer, I now have more empathy for people going through health crises, though when I see others posting inspirational stories on social media, I can’t help but to wonder how much strife they have actually been through.
June 27th 2022
By Brielle Benyon
The FDA approval of Breyanzi, a CAR-T cell therapy, offers patients with relapsed/refractory lymphoma the opportunity for long-term remission, and hope for a cure, one expert said.
June 27th 2022
By Kristie L. Kahl
Watch Dr. Suchita Pakkala, Dr. Jane Meisel, Dr. Keerthi Gogineni and Kelly Shanahan discuss updates in disease management during the CURE Educated Patient Metastatic Breast Cancer Summit.
June 27, 2022 5:00 PM
By Steve Rubin
June 24, 2022 5:00 PM
By Debbie Legault
June 23, 2022 9:00 PM
By William Ramshaw
June 23, 2022 5:00 PM
By Bonnie Annis
June 26, 2022 6:00 PM
June 25, 2022 6:00 PM
June 23, 2022 7:00 PM
June 23, 2022 1:00 PM
June 1, 2022 9:00 PM
By Pam Wilson
May 23, 2022 3:00 PM
By Kentisha Mazeke
May 19, 2022 7:00 PM
By Kimberly Holiday-Coleman
May 18, 2022 10:15 PM
By Tim McDonald
FDA Grants Orphan Drug Designation to Novel CAR-T Cell Therapy to Treat Waldenstrom Macroglobulinemia, a Rare Type of Cancer
New Resource ‘Empowers’ Patients With Breast Cancer That Has Spread to the Brain With Much Needed Information
Cancer Boosted My Empathy, But Anger Is Starting to Rear Its Head
FDA Approves Breyanzi for Previously Treated Large B-Cell Lymphoma